journal article·2016-02-10

Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots

Quanyin Hu, Wujin Sun, Yue Lu, Hunter N. Bomba, Yanqi Ye, Tianyue Jiang, Ari J. Isaacson, Zhen Gu

Nano Letters· Volume 16· Issue 2
Publisher page

Abstract

Protein therapy has been considered the most direct and safe approach to treat cancer. Targeting delivery of extracellularly active protein without internalization barriers, such as membrane permeation and endosome escape, is efficient and holds vast promise for anticancer treatment. Herein, we describe a "transformable" core-shell based nanocarrier (designated CS-NG), which can enzymatically assemble into microsized extracellular depots at the tumor site with assistance of hyaluronidase (HAase), an overexpressed enzyme at the tumor microenvironment. Equipped with an acid-degradable modality, the resulting CS-NG can substantially release combinational anticancer drugs-tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) and antiangiogenic cilengitide toward the membrane of cancer cells and endothelial cells at the acidic tumor microenvironment, respectively. Enhanced cytotoxicity on MDA-MB-231 cells and improved antitumor efficacy were observed using CS-NG, which was attributed to the inhibition of cellular internalization and prolonged retention time in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina 27695, United States

Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210000, Jiangsu China

Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27514, United States

Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States

Funding

National Center for Advancing Translational Sciences

References (57)

Show source-provided references
1. 10.1038/nrd239910.1038/nrd2399 ↗
2. 10.1038/nmat335510.1038/nmat3355 ↗
3. 10.1038/nrc125210.1038/nrc1252 ↗
4. 10.1038/nrc246510.1038/nrc2465 ↗
5. 10.1038/nnano.2009.34110.1038/nnano.2009.341 ↗
6. 10.1021/ja508083g10.1021/ja508083g ↗
7. 10.1038/nbt113710.1038/nbt1137 ↗
8. 10.1038/nrc323610.1038/nrc3236 ↗
9. 10.1002/adma.20120284710.1002/adma.201202847 ↗
10. 10.1038/nrc173610.1038/nrc1736 ↗
11. 10.1038/nrd266210.1038/nrd2662 ↗
12. 10.1038/nature0309810.1038/nature03098 ↗
13. 10.1038/sj.onc.120960810.1038/sj.onc.1209608 ↗
14. 10.1083/jcb.20011010810.1083/jcb.200110108 ↗
15. 10.1126/science.275.5303.113210.1126/science.275.5303.1132 ↗
16. 10.1021/nl902935b10.1021/nl902935b ↗
17. 10.1126/science.111503510.1126/science.1115035 ↗
18. 10.1039/c0cs00227e10.1039/c0cs00227e ↗
19. 10.1021/cr200157d10.1021/cr200157d ↗
20. 10.1038/nrc82110.1038/nrc821 ↗
21. 10.1007/s00262-011-1008-410.1007/s00262-011-1008-4 ↗
22. 10.1002/adfm.20130322210.1002/adfm.201303222 ↗
23. 10.1002/adma.20140449810.1002/adma.201404498 ↗
24. 10.1038/nrc206710.1038/nrc2067 ↗
25. 10.1038/nrc182110.1038/nrc1821 ↗
26. 10.1200/JCO.2006.06.651410.1200/JCO.2006.06.6514 ↗
27. 10.1097/00006123-200101000-0002610.1097/00006123-200101000-00026 ↗
28. 10.1038/nmat299210.1038/nmat2992 ↗
29. Keane M. M. · Cancer Res. · 1999 · 59 · 734
30. 10.1073/pnas.090303510610.1073/pnas.0903035106 ↗
31. 10.1200/JCO.2007.14.181210.1200/JCO.2007.14.1812 ↗
32. Bretschi M. · Oncol. Rep. · 2011 · 26 · 843
33. 10.1200/JCO.2008.16.751010.1200/JCO.2008.16.7510 ↗
34. 10.1021/bc800338n10.1021/bc800338n ↗
35. 10.1002/adma.20110125810.1002/adma.201101258 ↗
36. 10.1038/nrm101410.1038/nrm1014 ↗
37. 10.1021/ja508802410.1021/ja5088024 ↗
38. 10.1038/ncomms436410.1038/ncomms4364 ↗
39. 10.1038/srep0560010.1038/srep05600 ↗
40. 10.1021/cr050247k10.1021/cr050247k ↗
41. 10.1158/2159-8290.CD-11-013610.1158/2159-8290.CD-11-0136 ↗
42. 10.1038/nrd436310.1038/nrd4363 ↗
43. 10.1038/nnano.2012.26410.1038/nnano.2012.264 ↗
44. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
45. 10.1038/sj.onc.120629010.1038/sj.onc.1206290 ↗
46. 10.1016/j.biomaterials.2012.10.04810.1016/j.biomaterials.2012.10.048 ↗
47. 10.1038/3411210.1038/34112 ↗
48. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
49. 10.1073/pnas.150562911210.1073/pnas.1505629112 ↗
50. 10.1038/nrc311010.1038/nrc3110 ↗
51. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
52. 10.1038/nmat381910.1038/nmat3819 ↗
53. 10.1039/C4NR04249B10.1039/C4NR04249B ↗
54. 10.1021/acsnano.5b0356910.1021/acsnano.5b03569 ↗
55. 10.1016/j.jconrel.2014.08.01510.1016/j.jconrel.2014.08.015 ↗
56. 10.1016/j.addr.2015.10.02210.1016/j.addr.2015.10.022 ↗
57. 10.1038/ncomms1006610.1038/ncomms10066 ↗